IGC Pharma Inc (IGC)
0.4588
+0.01
(+3.08%)
USD |
NYAM |
Apr 23, 16:00
0.4588
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Price to Book Value: 3.230 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 22, 2024 | 3.134 |
April 19, 2024 | 3.450 |
April 18, 2024 | 3.352 |
April 17, 2024 | 4.129 |
April 16, 2024 | 3.422 |
April 15, 2024 | 3.092 |
April 12, 2024 | 3.098 |
April 11, 2024 | 3.731 |
April 10, 2024 | 3.738 |
April 09, 2024 | 4.048 |
April 08, 2024 | 4.365 |
April 05, 2024 | 4.573 |
April 04, 2024 | 4.857 |
April 03, 2024 | 4.508 |
April 02, 2024 | 3.77 |
April 01, 2024 | 3.351 |
March 28, 2024 | 2.816 |
March 27, 2024 | 2.862 |
March 26, 2024 | 2.809 |
March 25, 2024 | 2.816 |
March 22, 2024 | 2.647 |
March 21, 2024 | 2.394 |
March 20, 2024 | 2.425 |
March 19, 2024 | 2.663 |
March 18, 2024 | 2.387 |
Date | Value |
---|---|
March 15, 2024 | 2.284 |
March 14, 2024 | 2.368 |
March 13, 2024 | 2.344 |
March 12, 2024 | 2.289 |
March 11, 2024 | 2.341 |
March 08, 2024 | 2.345 |
March 07, 2024 | 2.323 |
March 06, 2024 | 2.312 |
March 05, 2024 | 2.361 |
March 04, 2024 | 2.457 |
March 01, 2024 | 2.464 |
February 29, 2024 | 2.426 |
February 28, 2024 | 2.457 |
February 27, 2024 | 2.409 |
February 26, 2024 | 2.457 |
February 23, 2024 | 2.133 |
February 22, 2024 | 1.901 |
February 21, 2024 | 1.978 |
February 20, 2024 | 2.054 |
February 16, 2024 | 2.112 |
February 15, 2024 | 2.087 |
February 14, 2024 | 2.085 |
February 13, 2024 | 2.078 |
February 12, 2024 | 2.112 |
February 09, 2024 | 2.147 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3983
Minimum
Mar 18 2020
6.550
Maximum
Feb 10 2021
1.687
Average
1.412
Median
Aug 31 2023
Price to Book Value Benchmarks
CEL-SCI Corp | 6.209 |
AIM ImmunoTech Inc | 2.183 |
NovaBay Pharmaceuticals Inc | 1.677 |
Protalix BioTherapeutics Inc | 2.622 |
Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 21.15 |
Price | 0.4588 |
Earnings Yield | -56.67% |
Market Cap | 29.24M |